Steven Stein

Dr. Stein has served as a member of the Board of Directors since October 2022. Dr. Stein currently serves as Executive Vice President, Chief Medical Officer of Incyte Corporation. Dr. Stein joined Incyte as Senior Vice President and Chief Medical Officer in March 2015, and has over 15 years of experience in clinical development and regulatory interactions. Dr. Stein joined Incyte from Novartis Pharmaceuticals Corporation, where he most recently served as Senior Vice President, U.S. Clinical Development & Medical Affairs at Novartis Oncology. Dr. Stein previously worked at GlaxoSmithKline as Vice President, Global Oncology, Clinical Development and as Head of Medicines Development for Hematology and Supportive Care. Dr. Stein earned his M.D. from the University of Witwatersrand in Johannesburg, South Africa.